Olema Pharmaceuticals, Inc. (OLMA)

Latest Insider Confidence Score

2026Q1

46.8
Bearish

Company insider confidence (by quarter)

2020Q4 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Bvf Partners L P/Il Director 11,514,471 Jun 13, 2025
Biotechnology Value Fund L P Director 11,514,471 Jun 13, 2025
Bvf I Gp Llc Director 11,514,471 Jun 13, 2025
Biotechnology Value Fund II Lp Director 11,514,471 Jun 13, 2025
Bvf II Gp Llc Director 11,514,471 Jun 13, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 3, 2026 Mar 5, 2026 Mitchell Shawnte CHIEF LEGAL OFFICER Sell 20.0 -40,000 -99.42% ✗ $951.5K
Feb 2, 2026 Feb 17, 2026 Austin Sasha Lu VP of Finance and Controller Neutral 90.0 +11,700 260.70% ✗ -
Feb 17, 2026 Austin Sasha Lu VP of Finance and Controller Neutral 52.5 - 0.00% ✗ -
Feb 2, 2026 Feb 4, 2026 Zojwalla Naseem CHIEF MEDICAL OFFICER Neutral 52.5 - 0.00% ✗ -
Feb 2, 2026 Feb 4, 2026 Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Neutral 52.5 - 0.00% ✗ -
Feb 2, 2026 Feb 4, 2026 Mitchell Shawnte CHIEF LEGAL OFFICER Neutral 52.5 - 0.00% ✗ -
Feb 2, 2026 Feb 4, 2026 Bohen Sean CEO Neutral 52.5 - 0.00% ✗ -
Jan 20, 2026 Jan 21, 2026 Harmon Cyrus Director Sell 20.0 -10,000 -1.17% ✗ $268.8K
Jan 14, 2026 Jan 16, 2026 Harmon Cyrus Director Sell 40.0 -3,489 -0.41% ✗ $101.6K
Jan 13, 2026 Jan 15, 2026 Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. Sell 17.5 -103,822 -42.63% ✗ $3M
Jan 12, 2026 Jan 14, 2026 Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Sell 17.5 -110,000 -4.47% ✗ $3.1M
Dec 26, 2025 Dec 30, 2025 Bohen Sean CEO Neutral 27.5 -8,500 -3.45% ✗ -
Dec 22, 2025 Dec 29, 2025 Harmon Cyrus Director Sell 40.0 -2,881 -0.33% ✗ $82.2K
Dec 19, 2025 Dec 23, 2025 CLARK IAN T Director Sell 16.3 -264,800 -100.00% ✗ $7.9M
Dec 19, 2025 Dec 23, 2025 Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Sell 17.5 -60,000 -7.79% ✗ $1.6M
Dec 19, 2025 Dec 23, 2025 Zojwalla Naseem Chief Medical Officer Sell 16.3 -269,509 -49.10% ✗ $7.5M
Dec 8, 2025 Dec 9, 2025 Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. Neutral 27.5 -75,000 -23.54% ✗ -
Nov 26, 2025 Dec 1, 2025 Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. Neutral 27.5 -225,000 -41.39% ✗ -
Nov 21, 2025 Nov 25, 2025 RAPPAPORT ANDREW Director Neutral 27.5 -35,868 -8.50% ✗ -
Sep 16, 2025 Sep 18, 2025 Harmon Cyrus Director Sell 22.5 -25,000 -2.82% ✗ $204.8K
Jun 11, 2025 Jun 13, 2025 BVF PARTNERS L P/IL Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 13, 2025 Larson Yi Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 13, 2025 Garland J. Scott Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 13, 2025 Horning Sandra Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 13, 2025 CLARK IAN T Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 13, 2025 Hrustanovic Gorjan Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 13, 2025 Graham G. Walmsley Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 13, 2025 Harmon Cyrus Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 13, 2025 BUTITTA CYNTHIA M Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 13, 2025 RAPPAPORT ANDREW Director Neutral 52.5 - 0.00% ✗ -
May 13, 2025 Graham G. Walmsley Director Neutral 52.5 - 0.00% ✗ -
Feb 28, 2025 Mar 3, 2025 Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Neutral 52.5 - 0.00% ✗ -
Feb 28, 2025 Mar 3, 2025 Zojwalla Naseem CHIEF MEDICAL OFFICER Neutral 52.5 - 0.00% ✗ -
Feb 28, 2025 Mar 3, 2025 Mitchell Shawnte CHIEF LEGAL OFFICER Neutral 52.5 - 0.00% ✗ -
Feb 28, 2025 Mar 3, 2025 Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. Neutral 52.5 - 0.00% ✗ -
Feb 28, 2025 Mar 3, 2025 Bohen Sean CEO Neutral 52.5 - 0.00% ✗ -
Feb 28, 2025 Mitchell Shawnte CHIEF LEGAL OFFICER Neutral 52.5 - 0.00% ✗ -
Jan 10, 2025 Jan 14, 2025 BVF PARTNERS L P/IL Director Neutral 27.5 -420,000 -7.60% ✗ -
Jan 8, 2025 Jan 13, 2025 Bain Capital Life Sciences Investors, LLC 10% Owner Buy 17.5 -3,200,000 -42.67% ✗ $1.7M
Jan 13, 2025 Bain Capital Life Sciences Investors, LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Dec 13, 2024 Dec 18, 2024 Graham G. Walmsley Director Neutral 52.5 - 0.00% ✗ -
Dec 17, 2024 Dec 17, 2024 Graham G. Walmsley Director Sell 16.3 -1,401,522 -49.87% ✗ $9.5M
Dec 16, 2024 Dec 17, 2024 Zojwalla Naseem CHIEF MEDICAL OFFICER Neutral 52.5 - 0.00% ✗ -
Dec 9, 2024 Dec 11, 2024 Harmon Cyrus Director Sell 82.5 +12,857 1.47% ✗ $148K
Dec 9, 2024 Dec 11, 2024 Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Sell 87.5 +22,684 3.05% ✗ $234.9K
Dec 9, 2024 Dec 11, 2024 Zojwalla Naseem CHIEF MEDICAL OFFICER Sell 97.5 +24,195 26.50% ✗ $250.5K
Dec 9, 2024 Dec 11, 2024 Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. Sell 92.5 +33,091 6.48% ✗ $316.7K
Dec 9, 2024 Dec 11, 2024 Bohen Sean CEO Sell 97.5 +95,248 65.05% ✗ $986.4K
Dec 4, 2024 Dec 4, 2024 BVF PARTNERS L P/IL Director Neutral 27.5 -3,369,704 -37.87% ✗ -
Jun 4, 2024 Nov 26, 2024 Graham G. Walmsley Director Sell 15.0 -1,175,000 -45.47% ✗ $17.4M
Nov 15, 2024 Nov 18, 2024 Kovacs Shane William Charles Ch. Operating & Financial Off. Neutral 52.5 - 0.00% ✗ -
Aug 1, 2024 Aug 5, 2024 Paradigm Biocapital Advisors LP 10% Owner Sell 15.0 -2,400,000 -30.37% ✗ $35.8M
Jul 29, 2024 Jul 31, 2024 Harmon Cyrus Director Sell 47.5 -5,000 -0.57% ✓ $77.9K
Jul 11, 2024 Jul 12, 2024 Harmon Cyrus Director Sell 47.5 -5,000 -0.57% ✓ $61.3K
Jun 28, 2024 Jul 2, 2024 Harmon Cyrus Director Sell 41.3 -20,000 -2.21% ✓ $215.4K
Jun 14, 2024 Jun 18, 2024 BVF PARTNERS L P/IL Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2024 Jun 18, 2024 Horning Sandra Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2024 Jun 18, 2024 Graham G. Walmsley Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2024 Jun 18, 2024 RAPPAPORT ANDREW Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2024 Jun 18, 2024 Harmon Cyrus Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2024 Jun 18, 2024 Larson Yi Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2024 Jun 18, 2024 Hrustanovic Gorjan Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2024 Jun 18, 2024 CLARK IAN T Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2024 Jun 18, 2024 Garland J. Scott Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2024 Jun 18, 2024 BUTITTA CYNTHIA M Director Neutral 52.5 - 0.00% ✗ -
Jun 4, 2024 Jun 6, 2024 Graham G. Walmsley Director Sell 15.0 -1,175,000 -45.47% ✗ $17.4M
May 31, 2024 Jun 4, 2024 Harmon Cyrus Director Sell 38.8 -25,000 -2.69% ✓ $257.5K
May 24, 2024 May 28, 2024 Zojwalla Naseem CHIEF MEDICAL OFFICER Neutral 52.5 - 0.00% ✗ -
May 6, 2024 May 7, 2024 Harmon Cyrus Director Sell 47.5 -5,000 -0.54% ✓ $54.6K
Apr 30, 2024 May 2, 2024 Harmon Cyrus Director Sell 45.0 -15,000 -1.58% ✓ $142.7K
Mar 28, 2024 Mar 29, 2024 Harmon Cyrus Director Sell 41.3 -20,000 -2.07% ✓ $219.4K
Mar 18, 2024 Mar 20, 2024 Zojwalla Naseem CHIEF MEDICAL OFFICER Neutral 52.5 - 0.00% ✗ -
Mar 5, 2024 Mar 6, 2024 RAPPAPORT ANDREW Director Neutral 27.5 -95,049 -19.76% ✗ -
Feb 29, 2024 Mar 4, 2024 Harmon Cyrus Director Sell 38.8 -25,000 -2.52% ✓ $310.3K
Feb 1, 2024 Feb 5, 2024 Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Neutral 52.5 - 0.00% ✗ -
Feb 1, 2024 Feb 5, 2024 Zojwalla Naseem CHIEF MEDICAL OFFICER Neutral 52.5 - 0.00% ✗ -
Feb 1, 2024 Feb 5, 2024 Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. Neutral 52.5 - 0.00% ✗ -
Feb 1, 2024 Feb 5, 2024 Bohen Sean CEO Neutral 52.5 - 0.00% ✗ -
Jan 31, 2024 Feb 2, 2024 Harmon Cyrus Director Sell 38.8 -30,000 -2.93% ✓ $383.6K
Jan 25, 2024 Jan 29, 2024 Zojwalla Naseem CHIEF MEDICAL OFFICER Neutral 52.5 - 0.00% ✗ -
Jan 12, 2024 Jan 16, 2024 Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. Neutral 52.5 - 0.00% ✗ -
Dec 29, 2023 Jan 2, 2024 Harmon Cyrus Director Sell 38.8 -25,000 -2.38% ✓ $334.5K
Sep 12, 2023 Dec 18, 2023 Graham G. Walmsley Director Buy 100.0 +640,000 55.17% ✗ $6.9M
Dec 12, 2023 Dec 12, 2023 Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. Neutral 52.5 - 0.00% ✗ -
Dec 11, 2023 Dec 12, 2023 Zojwalla Naseem CHIEF MEDICAL OFFICER Neutral 52.5 - 0.00% ✗ -
Dec 6, 2023 Dec 8, 2023 Paradigm Biocapital Advisors LP 10% Owner Buy 87.5 +100,000 1.28% ✗ $1.2M
Dec 6, 2023 Dec 7, 2023 Zojwalla Naseem CHIEF MEDICAL OFFICER Neutral 52.5 - 0.00% ✗ -
Dec 7, 2023 Zojwalla Naseem CHIEF MEDICAL OFFICER Neutral 52.5 - 0.00% ✗ -
Nov 30, 2023 Dec 1, 2023 Harmon Cyrus Director Sell 38.8 -25,000 -2.33% ✓ $314.3K
Nov 20, 2023 Nov 22, 2023 Harmon Cyrus Director Sell 72.5 +7,569 0.71% ✗ $117.7K
Nov 20, 2023 Nov 22, 2023 Zojwalla Naseem CHIEF MEDICAL OFFICER Sell 95.0 +13,444 78.07% ✗ $209.3K
Nov 20, 2023 Nov 22, 2023 Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Sell 82.5 +12,621 1.73% ✗ $196.2K
Nov 20, 2023 Nov 22, 2023 Bohen Sean CEO Sell 97.5 +53,025 57.70% ✗ $824.1K
Nov 20, 2023 Nov 22, 2023 Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. Sell 90.0 +18,008 4.42% ✗ $269.7K
Nov 8, 2023 Nov 13, 2023 Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Sell 58.8 -200 -0.03% ✓ $3.5K
Nov 1, 2023 Nov 3, 2023 Myles David C. CH. DISCOV. & NON-CLIN DEV OFF Sell 45.0 -10,541 -1.43% ✓ $160.8K
Oct 31, 2023 Nov 2, 2023 Harmon Cyrus Director Sell 38.8 -30,000 -2.74% ✓ $379.5K
Oct 16, 2023 Oct 17, 2023 Garland J. Scott Director Neutral 52.5 - 0.00% ✗ -
Oct 17, 2023 Garland J. Scott Director Neutral 52.5 - 0.00% ✗ -
Sep 29, 2023 Oct 3, 2023 Harmon Cyrus Director Sell 38.8 -25,000 -2.23% ✓ $310.3K